RecruitingNCT02869529
Institut Paoli Calmettes Chronic Lymphatic Leukemia Database
Sponsor
Institut Paoli-Calmettes
Enrollment
4,200 participants
Start Date
Jan 1, 2006
Study Type
OBSERVATIONAL
Conditions
Summary
Database of Institut Paoli-Calmettes patients diagnosed with chronic lymphatic leukemia
Eligibility
Min Age: 18 YearsMax Age: 95 Years
Inclusion Criteria1
- Diagnosis of chronic lymphatic leukemia
Exclusion Criteria1
- Score of Matutes \<4
Interventions
OTHERData collection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02869529
Related Trials
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
NCT0596307473 locations
Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia
NCT062995401 location
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
NCT0594785152 locations
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
NCT0333119886 locations
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
NCT063644231 location